AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17440161
Drug: PELFw regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PELFw regimen (8 weekly administrations of cisplatin 40 mg/m2, LV 250 mg/m2, epidoxorubicin 35 mg/m2, 5-FU 500 mg/m2, glutathione 1.5 g/m2 with filgrastim)
Trial: 17440161
Drug: 5-FU/LV regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU/LV regimen (6 monthly administrations of a 5-day course of 5-FU 375 mg/m2 daily and LV 20 mg/m2 daily)
Trial: 12123399
Drug: 1000 mg/d
RxNorm normalized name: RibaTab 1000 MG/day Compliance Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg/d ER niacin
Trial: 12123399
Drug: 1500 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg/d ER niacin
Trial: 10354968
Drug: Indinavir (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir (800 mg every 8 hours from days 2 to 7)
Trial: 9420871
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of micronized estradiol and progesterone (n = 7)
Trial: 7316248
Drug: Rush Immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rush Immunotherapy (IT) with four Ag dilutions: 10, 100, 1000, and 5000 pnu/ml, maintenance dose of 0.5 ml of the 5000 pnu/ml solution achieved in 7 to 18 weeks (mean 12 weeks).
Trial: 30993855
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 300 units/mL (Gla-300)
Trial: 17317857
Drug: Dasatinib (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasatinib (140 mg)
Trial: 15345173
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy (He-Ne laser applied to three trigger points in the upper trapezius muscles with 632.8 nm)
Trial: 31186177
Drug: Automated Bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated Bone Scan Index (aBSI) increase during treatment
Trial: 27564283
Drug: Doxazosin Oral
RxNorm normalized name: doxazosin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin Oral Intake Therapy (4 mg once daily for 4 weeks)
Trial: 27564283
Drug: Doxazosin Oral
RxNorm normalized name: doxazosin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin Oral Intake Therapy
Trial: 24169147
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 10 mg PO twice daily for six weeks
Trial: 20407232
Drug: Late GH
RxNorm normalized name: FUSION PROTEIN OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG- .BETA.)-(118-145)-PEPTIDE (1-28) WITH HUMAN SOMATOTROPIN (GROWTH HORMONE, GH) (29-219) AND TWO TANDEM COPIES OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG-.BETA.)-(118-145)- PEPTIDE (220-247
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late GH therapy (0.46 mg/kg/week)
Trial: 20407232
Drug: Early GH
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early GH therapy (0.46 mg/kg/week)
Trial: 20407232
Drug: No GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No GH therapy (Control)
Trial: 9183129
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) titrated to a target dose of 0.7 mg/kg twice a day
Trial: 3895761
Drug: Bepridil 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bepridil 600 mg/day
Trial: 30679315
Drug: Gemcitabine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1,000 mg/m2 on days 1, 8, and 15 of a 28-day cycle with erlotinib 100 mg p.o. daily (Arm A)
Trial: 30679315
Drug: Gemcitabine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1,000 mg/m2 on days 1, 8, and 15 of a 28-day cycle with erlotinib 100 mg p.o. daily and panitumumab 4 mg/kg on days 1 and 15 of a 28-day cycle (Arm B)
Trial: 21470787
Drug: High-dose external-beam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose external-beam radiation therapy (EBRT) (79.2 Gray equivalent using photons and protons)
Trial: 19865063
Drug: Alprazolam 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 1.5 mg daily
Trial: 11548897
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg Ginkgo biloba extract EGb 761 twice daily
Trial: 11548897
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg Ginkgo biloba extract EGb 761 twice daily
Trial: 7936250
Drug: 1H‐MRSI in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1H‐MRSI in sequential studies
Trial: 3124453
Drug: Thymopentin treatment
RxNorm normalized name: thymopentin
DrugBank: Thymopentin (DB11996)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymopentin treatment (50 mg s.c. 3 times/week for 3 weeks and repeated after 3 months at 50 mg s.c. once a week for 3 months)
Trial: 28554739
Drug: Descriptive norms
RxNorm normalized name: K Norm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Descriptive norms questions (e.g., 'What do you do with bikes?')
Trial: 28554739
Drug: Preference questions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preference questions (e.g., 'What do you like to do with bikes?')
Trial: 28554739
Drug: Prescriptive norms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescriptive norms questions (e.g., 'What should you do with books?')
Trial: 28554739
Drug: Preference questions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preference questions (e.g., 'What do you like about books?')
Trial: 27889725
Drug: 25 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mL/kg IV normal saline over 6-8 hours
Trial: 23510951
Drug: Ginger (1g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (1g capsules, two doses: one before induction and one 2h after surgery)
Trial: 7767852
Drug: Ceftriaxone 1.5g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 1.5g once daily
Trial: 7767852
Drug: Cefotaxime 6g
DrugBank: Cefotaxime (DB00493)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotaxime 6g divided into four daily doses
Trial: 2150591
Drug: CGS 16949A
RxNorm normalized name: Alkamide 101-cg
DrugBank: Coco diethanolamide (DB18828)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS 16949A 0.9 mg
Trial: 2150591
Drug: CGS 16949A
RxNorm normalized name: Alkamide 101-cg
DrugBank: Coco diethanolamide (DB18828)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS 16949A 0.6 mg
Trial: 25574686
Drug: GS-5806 (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GS-5806 (oral RSV fusion inhibitor)
Trial: 15472665
Drug: 1-visit root
RxNorm normalized name: Mugwort root
DrugBank: Artemisia vulgaris root (DB14170)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-visit root canal treatment using AH 26 sealer and laterally compacted gutta-percha
Trial: 15472665
Drug: 2-visit root
RxNorm normalized name: Mugwort root
DrugBank: Artemisia vulgaris root (DB14170)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-visit root canal treatment with calcium hydroxide-chlorhexidine medication and temporary filling
Trial: 8980871
Drug: light or
RxNorm normalized name: lake blend light orange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: light or medication
Trial: 3138303
Drug: Enprostil (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprostil (35 micrograms twice daily)
Trial: 19291121
Drug: Solvent-free (SF)
RxNorm normalized name: solvent yellow 18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solvent-free (SF) formulation
Trial: 19291121
Drug: Solvent-containing (SC)
RxNorm normalized name: solvent yellow 18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solvent-containing (SC) formulation
Trial: 16790651
Drug: HIGH-group: 9.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIGH-group: 9.5 mg hyperbaric bupivacaine + 2.5 microg sufentanil
Trial: 16790651
Drug: LOW-group: 6.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LOW-group: 6.5 mg hyperbaric bupivacaine + 2.5 microg sufentanil
Trial: 11105535
Drug: Conventional amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional amphotericin B 1 mg kg‐1 per day
Trial: 11105535
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B 1 mg kg‐1 per day
Trial: 11105535
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B 3 mg kg‐1 per day
Trial: 11105535
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B 1 mg kg‐1
Trial: 11105535
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B 3 mg kg‐1
Trial: 3885425
Drug: Metronidazole tablets
RxNorm normalized name: Metronidazole Tablets
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole tablets (2 g single dose)
Trial: 3885425
Drug: Benzoyl metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl metronidazole suspension (2 g single dose)
Trial: 3885425
Drug: Tinidazole tablets
RxNorm normalized name: Tinidazole Tablets
DrugBank: Tinidazole (DB00911)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tinidazole tablets (2 g single dose)
Trial: 3611299
Drug: Oral influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral influenza immunization in elderly volunteers
Trial: 3611299
Drug: Oral influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral influenza immunization in young mice
Trial: 3611299
Drug: Oral influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral influenza immunization in older mice
Trial: 3611299
Drug: Oral influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral influenza immunization
Trial: 3611299
Drug: Parenteral influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral influenza immunization
Trial: 3611299
Drug: Secretory IgA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secretory IgA (SIgA) antibody response
Trial: 3611299
Drug: Salivary antibody
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salivary antibody response in elderly
Trial: 18444059
Drug: Evidence-based psychosocial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based psychosocial treatments (EBTs)
Trial: 16434737
Drug: Fluoride varnish
RxNorm normalized name: Hydrogen fluoride
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride varnish twice/year
Trial: 10882226
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid (fluticasone propionate, FP, 250 microg twice daily)
Trial: 10882226
Drug: Short-acting beta-agonist
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting beta-agonist (salbutamol, Sb, 400 microg twice daily)
Trial: 8267238
Drug: Conventional heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional heparin lock
Trial: 3884131
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) + semustine (MeCCNU) chemotherapy
Trial: 28759735
Drug: 250 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mL of 2% fat milk
Trial: 28759735
Drug: 250 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mL of soy beverage
Trial: 28759735
Drug: 175 g
RxNorm normalized name: ALCOHOL 14.175 g in 10 / BENZALKONIUM CHLORIDE 0.042 g in 10 / DIDECYLDIMONIUM CHLORIDE 0.0567 g in 10 TOPICAL CLOTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 175 g of 2% Greek yogurt
Trial: 28759735
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of Cheddar cheese
Trial: 19142758
Drug: Olmesartan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (20 mg/day) administered at bedtime
Trial: 19142758
Drug: Olmesartan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (20 mg/day) administered upon awakening
Trial: 17209146
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment in MDD-HF subjects
Trial: 15025735
Drug: Fluticasone proprionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone proprionate (FP) 2000 micro g daily for 2 weeks
Trial: 11862344
Drug: buprenorphine/naloxone (4/1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buprenorphine/naloxone (4/1, 8/2, 16/4, 32/8 mg)
Trial: 11862344
Drug: buprenorphine (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buprenorphine (32 mg)
Trial: 9814400
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin (50 mg/kg/day divided tid)
Trial: 9814400
Drug: Intramuscular penicillin
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular penicillin (50,000 units/kg)
Trial: 2796618
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL of 0.5% Bupivacaine
Trial: 2796618
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL of 0.5% Bupivacaine with 1 mL 10% G/W
Trial: 2796618
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL of 0.5% Bupivacaine with 1 mL 10% G/W
Trial: 2796618
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL of 0.5% Bupivacaine in 8% glucose
Trial: 2796618
Drug: 4 mL
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mL of hyperbaric Bupivacaine
Trial: 648737
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride (Slow‐K 600 mg three times daily)
Trial: 648737
Drug: Spironolactone (Aldactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (Aldactone A 25 mg four times daily)
Trial: 31293259
Drug: Early oral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early oral feeding (initiated at 8 hours post-operation)
Trial: 31293259
Drug: Delayed oral
RxNorm normalized name: lipase 12,000 UNT / amylase 39,000 UNT / protease 39,000 UNT Delayed Oral Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed oral feeding (initiated at 48 hours post-operation)
Trial: 31293259
Drug: Delayed oral
RxNorm normalized name: lipase 12,000 UNT / amylase 39,000 UNT / protease 39,000 UNT Delayed Oral Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed oral feeding
Trial: 23416857
Drug: Methamphetamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methamphetamine (20 mg, oral) in paired conditions with contextual cues
Trial: 23416857
Drug: Methamphetamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methamphetamine (20 mg, oral) in unpaired conditions
Trial: 21203888
Drug: Treadmill exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treadmill exercise at 65% of peak VO2 for 1 hour during MF and ML phases
Trial: 19671089
Drug: Tramadol Contramid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol Contramid OAD 100 mg
Trial: 17460496
Drug: Cow's milk
RxNorm normalized name: Cow's milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cow's milk (CM) with fish oil (FO) supplement
Trial: 17460496
Drug: Infant formula
RxNorm normalized name: Infant formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant formula (IF) with fish oil (FO) supplement
Trial: 11783823
Drug: Acupuncture, transcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture, transcutaneous electrical nerve stimulation, acupuncture‐like transcutaneous nerve stimulation, laser therapy, neuroreflexotherapy
Trial: 9493258
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A treatment (one capsule)
Trial: 9493258
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A treatment (two doses)
Trial: 9493258
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A treatment (no pills taken)
Trial: 18719064
Drug: Linezolid (LZD),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (LZD), 600 mg
Trial: 18719064
Drug: Vancomycin (VAN),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (VAN), 1 g every 12 h
Trial: 10704632
Drug: Atorvastatin (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (initial dose 10 mg, max 80 mg)
Trial: 10704632
Drug: Simvastatin (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (initial dose 10 mg, max 40 mg, supplemented with 4 g cholestyramine if necessary)
Trial: 10704632
Drug: Atorvastatin (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (for baseline cholesterol 5.6-6.5 mmol/l)
Trial: 10704632
Drug: Simvastatin (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (for baseline cholesterol 5.6-6.5 mmol/l)
Trial: 10704632
Drug: Atorvastatin (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (for baseline cholesterol 7.6-8.5 mmol/l)
Trial: 10704632
Drug: Simvastatin (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (for baseline cholesterol 7.6-8.5 mmol/l)
Trial: 9346224
Drug: Paclitaxel (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (175 mg/m2) with carboplatin (AUC 7)
Trial: 9346224
Drug: Paclitaxel (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (175 mg/m2) with carboplatin (AUC 7) alternating with cisplatin (75 mg/m2)
Trial: 2637911
Drug: PT-01 (controlled-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT-01 (controlled-release insert containing ofloxacin)
Trial: 25423960
Drug: S-1 adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 adjuvant chemotherapy (S-1(+)-group) administered after 2003
Trial: 25423960
Drug: No S-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No S-1 adjuvant chemotherapy (S-1(-)-group) before 2003
Trial: 23530078
Drug: Combination artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Combination artesunate (AS)/amodiaquine (AQ) therapy
Trial: 15499517
Drug: Liposome eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposome eye spray (TEARS AGAIN, Optima Pharmaceutical GmbH, Germany)
Trial: 15499517
Drug: Liposome eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposome eye spray (TEARS AGAIN)
Trial: 11755562
Drug: Atenolol therapy
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol therapy for high cardiac output (greater than 7.4 L/minute)
Trial: 1720486
Drug: isradipine 1.25-2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isradipine 1.25-2.5 mg twice daily
Trial: 1720486
Drug: metoprolol 50-100
RxNorm normalized name: hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: metoprolol 50-100 mg twice daily
Trial: 6817845
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate treatment for 6 months
Trial: 6817845
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C treatment for 6 months
Trial: 29962032
Drug: G‐CSF with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF with EPO (Group A; n = 30)
Trial: 29962032
Drug: G‐CSF and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF and placebo (Group B; n = 30)
Trial: 26380359
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Group Therapy (CBGT), 12 sessions
Trial: 23585303
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of biapenem 0.15 g
Trial: 23585303
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of biapenem 0.3 g
Trial: 23585303
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of biapenem 0.6 g
Trial: 23585303
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of biapenem 0.3 g